PATENT CLAIM ANALYSIS

Application Number: 15974190
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "298000"]

Abstract:
The present invention describes new amino pyrimidine derivatives and pharmaceutically acceptable salts thereof which appear to interact with Bruton's tyrosine kinase (Btk). Accordingly, the novel amino pyrimidines may be effective in the treatment of autoimmune disorders, inflammatory diseases, allergic diseases, airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), transplant rejection, cancers e.g. of hematopoietic origin or solid tumors.

Claim (Index 10):
The method of  claim 1 , wherein\n R1 is C 1 -C 6  alkyl; R2 is fluoro; R3 is hydrogen; R4 is hydrogen; R5 is fluoro; R6 and R7 stand independently from each other for H, C 3 -C 6  cycloalkyl, or halogen; R8, R9, R10 and R11 stand for H; R12 is hydrogen; n is 0; and R13 is C 2 -C 6  alkenyl optionally substituted by C 1 -C 6  alkyl.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 93.0
- Lexical Diversity: 1.26667
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14540140', '14112559', '13808430', '14235477', '14130536']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7489551037347593
- 35 USC 102 Novelty (BERT): 0.5636564997602719
- Combined Prediction Score: 0.7304252433373106
- Mean Citation Score: 298.510174
- Max Citation Score: 434.1317
- Similarity Product: 367.3893323532283

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test